David F Yankelevitz
Overview
Explore the profile of David F Yankelevitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
196
Citations
3246
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gros L, Yip R, Flores R, Zhang J, Paksashvili N, Zhang L, et al.
Lung Cancer
. 2025 Mar;
202:108465.
PMID: 40043632
Background: Increased lung cancer screening has made early-stage non-small-cell lung cancer (NSCLC) more common, with lung-sparing surgery as the standard curative treatment. Our study evaluated patients who underwent surgery for...
2.
Lancaster H, Walstra A, Myers K, Avila R, Gratama J, Heuvelmans M, et al.
Eur J Cancer
. 2025 Mar;
220:115323.
PMID: 40022837
Reduction in lung cancer mortality is achievable through low dose computed tomography (LDCT) screening in high-risk individuals. Many countries are progressing from local LDCT screening studies to national screening programs....
3.
Mulshine J, Pyenson B, Healton C, Aldige C, Avila R, Blum T, et al.
Eur J Cancer
. 2025 Feb;
218:115264.
PMID: 39904127
Large-scale lung cancer screening implementation combined with improvements in early detection techniques for three major tobacco-related diseases presents a rare opportunity to markedly improve population health outcomes for millions of...
4.
Lewis J, Stranick A, Pennings J, Samuels L, Byerly S, Helton J, et al.
Am J Prev Med
. 2025 Jan;
PMID: 39880059
Introduction: Lung cancer screening is underutilized, especially in rural areas where lung cancer mortality is high. Approximately 11.2% of the U.S. population over age 50 years meet the U.S. Preventive...
5.
Gros L, Yip R, Golombeck A, Yankelevitz D, Henschke C
JTO Clin Res Rep
. 2025 Jan;
6(2):100777.
PMID: 39877030
Introduction: Limited information exists on next-generation sequencing (NGS) success for lung tumors of 30 mm or less. We aimed to compare NGS success rates across biopsy techniques for these tumors,...
6.
Tammemagi M, Borondy-Kitts A, Field J, Henschke C, Mohan A, Kerpel-Fronius A, et al.
J Thorac Oncol
. 2025 Jan;
PMID: 39864549
Introduction: Lung cancer screening (LCS) using low-dose-computed tomography reduces lung cancer mortality in high-risk individuals. Evaluating and monitoring LCS programs are important to ensure and improve quality, efficiency and participant...
7.
Zhu Y, Yankelevitz D, Henschke C
Radiology
. 2025 Jan;
314(1):e240091.
PMID: 39835978
Lung cancer is the leading cause of cancer deaths globally. In various trials, the ability of low-dose CT screening to diagnose early lung cancers leads to high cure rates. It...
8.
Sun Q, Li P, Zhang J, Yip R, Yankelevitz D, Henschke C
Radiology
. 2025 Jan;
314(1):e240599.
PMID: 39807982
Background Angiolymphatic invasion (ALI) is an important prognostic indicator in non-small cell lung cancer (NSCLC). However, few studies focus on radiologic features for predicting ALI in patients with early-stage NSCLCs...
9.
Naghavi M, Reeves A, Atlas K, Zhang C, Li D, Atlas T, et al.
JACC Adv
. 2025 Jan;
3(11):101300.
PMID: 39741645
Background: AI-CAC provides more actionable information than the Agatston coronary artery calcium (CAC) score. We have recently shown in the MESA (Multi-Ethnic Study of Atherosclerosis) that AI-CAC automated left atrial...
10.
Yankelevitz D, Oudkerk M, Henschke C
Arch Bronconeumol
. 2024 Dec;
61(3):129-131.
PMID: 39741043
No abstract available.